Clinical Trial Update: Study of Aspirin in Patients With Vestibular Schwannoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for aspirin in vestibular schwannoma patients; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type
• Vestibular Schwannoma

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Vestibular Schwannoma, Acoustic Neuroma | Phase 2 | Status: ACTIVE_NOT_RECRUITING